In neurodegenerative diseases, such as AD, CD200 is downregulated in human brains [77], and forced overexpression in the brain of CD200 promotes neurogenesis and ameliorates pathology in a mouse model of AD [79]. This evidence concerns the gene CD200 and Alzheimer disease.